コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ding kinase 1, inducible IkappaB kinase, and interferon regulatory factor 3.
2 pressing constitutively active NF-kappaB and interferon regulatory factor 3.
3 al responses including activation of PKR and interferon regulatory factor 3.
4 r double-stranded RNA-mediated activation of interferon regulatory factor 3, a transcription factor t
5 al for innate immune signaling of downstream interferon regulatory factor 3 activation and interferon
8 sion of the shRNA results in dimerization of interferon regulatory factor-3, activation of IFN promot
10 anscription factors was increased, including interferon regulatory factor 3 and 7 (IRF-3 and IRF-7) a
12 ciated with increased baseline expression of interferon regulatory factor 3 and 7 mRNAs and productio
13 dent and -independent pathways that activate interferon regulatory factor 3 and cytokine expression.
14 r and blocking downstream activation of both interferon regulatory factor 3 and nuclear factor kappa
15 on and decreased the nuclear accumulation of interferon regulatory factors 3 and 7 (IRF3 and -7) and
16 ase beta (IKKB), IkappaB kinase iota (IKKI), interferon regulatory factors 3 and 7, and rhinovirus in
18 ator of interferon genes-TANK-binding kinase-interferon regulatory factor 3 (cGAS-STING-TBK1-IRF3) si
21 l28ra(-/-)), and mice with disruption of the interferon regulatory factor 3 gene (Irf3(-/-)), with or
22 including E6AP, ERC55, paxillin, hDlg, p300, interferon regulatory factor 3, hMCM7, Bak, and E6TP1.
23 s showed greater activation of NF-kappaB and interferon regulatory factor 3 in response to LPS and po
24 directed by a constitutively active form of interferon regulatory factor 3 (IRF-3 5D), and IRF-3 is
26 the signal through the transcription factors interferon regulatory factor 3 (IRF-3) and nuclear facto
27 the early IFN-beta and -alpha1 response are interferon regulatory factor 3 (IRF-3) and nuclear facto
29 ng pathways that lead to viral activation of interferon regulatory factor 3 (IRF-3) and synthesis of
31 ponents of DRAF1 have now been identified as interferon regulatory factor 3 (IRF-3) and the transcrip
32 sponses mediated by the transcription factor interferon regulatory factor 3 (IRF-3) are often vital f
33 actors nuclear factor kappaB (NF-kappaB) and interferon regulatory factor 3 (IRF-3) at a step subsequ
35 e models, the antiviral transcription factor interferon regulatory factor 3 (IRF-3) enhances reovirus
36 s found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containi
41 ltimeric transcription factor containing the interferon regulatory factor 3 (IRF-3) protein and one o
45 protease, Sendai virus-induced activation of interferon regulatory factor 3 (IRF-3), a key antiviral
46 ron response by inhibiting the activation of interferon regulatory factor 3 (IRF-3), a key regulator
47 Nile virus NY (WNV-NY) delays activation of interferon regulatory factor 3 (IRF-3), a transcription
48 us-induced phosphorylation and activation of interferon regulatory factor 3 (IRF-3), a transcription
49 the latent transcription factors NF-kappaB, interferon regulatory factor 3 (IRF-3), and ATF-2, which
50 n in vitro, class II transactivator (CIITA), interferon regulatory factor 3 (IRF-3), and interferon r
51 yxovirus infection induces apoptosis through interferon regulatory factor 3 (IRF-3), but the exact me
52 actors nuclear factor kappaB (NF-kappaB) and interferon regulatory factor 3 (IRF-3), classically indu
53 ocation of the IFN-beta transcription factor interferon regulatory factor 3 (IRF-3), MHV did not indu
54 ponse, as characterized by the activation of interferon regulatory factor 3 (IRF-3), production of in
56 ating signaling that activates NF-kappaB and interferon regulatory factor 3 (IRF-3), thereby inducing
57 hibited poly(I.C)-induced phosphorylation of interferon regulatory factor 3 (IRF-3), which is the key
58 key proapoptotic protein in this pathway is interferon regulatory factor 3 (IRF-3), which upon activ
59 inhibited activation of beta interferon and interferon regulatory factor 3 (IRF-3)-dependent promote
67 involves activation of transcription factors interferon regulatory factor-3 (IRF-3) and NF-kappaB, re
68 and suppressed the downstream activation of interferon regulatory factor-3 (IRF-3) and nuclear facto
71 this study we have defined the mechanisms of interferon regulatory factor-3 (IRF-3) signaling in prim
73 s the phosphorylation and effector action of interferon regulatory factor-3 (IRF-3), a key cellular a
74 HeLa cells, EV68 inhibits poly(I.C)-induced interferon regulatory factor 3 (IRF3) activation and bet
75 We have identified potential pathways, via interferon regulatory factor 3 (IRF3) activation or Hoxa
76 (IFN-I) production through inhibition of the interferon regulatory factor 3 (IRF3) activation pathway
77 1 and -2 was required for phosphorylation of interferon regulatory factor 3 (IRF3) and accumulation o
78 sed S. pneumoniae induced phosphorylation of interferon regulatory factor 3 (IRF3) and activating tra
79 onse to microbial components, TBK1 activates interferon regulatory factor 3 (IRF3) and cytokine expre
80 s) required for initiating the activation of interferon regulatory factor 3 (IRF3) and interferon (IF
82 stimulator 1 (IPS-1)-mediated activation of interferon regulatory factor 3 (IRF3) and NF-kappaB sign
83 ents and activation of transcription factors interferon regulatory factor 3 (IRF3) and NF-kappaB, STI
84 tion of two inducible transcription factors, interferon regulatory factor 3 (IRF3) and NF-kappaB.
86 r proteins leading to activation of both the interferon regulatory factor 3 (IRF3) and nuclear factor
87 nscription via transcription factors such as interferon regulatory factor 3 (IRF3) and nuclear factor
89 phosphorylation of the transcription factor interferon regulatory factor 3 (IRF3) and subsequent exp
90 ds to activation of the transcription factor interferon regulatory factor 3 (IRF3) and subsequent tra
91 -dependent phosphorylation and activation of Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquit
92 TBK1 phosphorylates the transcription factor Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquit
93 then bind to a positively charged surface of interferon regulatory factor 3 (IRF3) and thereby recrui
95 ls by preventing not only phosphorylation of interferon regulatory factor 3 (IRF3) but also degradati
96 d not bind MDA5 efficiently, did not inhibit interferon regulatory factor 3 (IRF3) dimerization or IF
98 nse to viral infection by degradation of the interferon regulatory factor 3 (IRF3) has been subject o
99 of the immune signaling transcription factor interferon regulatory factor 3 (IRF3) in response to cyt
100 ndrial antiviral signaling protein (MAVS) or interferon regulatory factor 3 (IRF3) in the IFN inducti
101 on of ZAP occurs under the direct control of interferon regulatory factor 3 (IRF3) independent of int
106 y and confirmed that these miRNAs potentiate interferon regulatory factor 3 (IRF3) phosphorylation an
107 (iii) delivery of the viral genome triggers interferon regulatory factor 3 (IRF3) phosphorylation, a
108 nduction of TBK1 alone is not sufficient for interferon regulatory factor 3 (IRF3) phosphorylation.
112 activation of the TANK-binding kinase (TBK1)-interferon regulatory factor 3 (IRF3) signalling axis to
113 tiviral interferon antagonist which degrades interferon regulatory factor 3 (IRF3) through the protea
114 ntly phosphorylates the transcription factor interferon regulatory factor 3 (IRF3) to promote interfe
115 antagonist capable of blocking activation of interferon regulatory factor 3 (IRF3) via the retinoic a
116 ta but not IFN-gamma, and both NF-kappaB and interferon regulatory factor 3 (IRF3) were required.
117 sible for HIV-1 targeting and degradation of interferon regulatory factor 3 (IRF3), a central transcr
121 cells causes partial proteolytic cleavage of interferon regulatory factor 3 (IRF3), a key transcripti
123 ng cause, we determined the effect of E3L on interferon regulatory factor 3 (IRF3), a transcription f
125 at least in part, of the recently identified interferon regulatory factor 3 (IRF3), but it does not c
126 hondrial antiviral signaling protein (MAVS), interferon regulatory factor 3 (IRF3), or Interferon-alp
127 uit TANK-binding kinase 1 (TBK1) to activate interferon regulatory factor 3 (IRF3), resulting in prod
128 epatitis C virus (HCV) genomic RNA activates interferon regulatory factor 3 (IRF3), thereby inducing
129 E) inhibits TBK1-mediated phosphorylation of interferon regulatory factor 3 (IRF3), which is essentia
130 paB, commonly activated by several TLRs, and interferon regulatory factor 3 (IRF3), which was found t
131 s alcoholic liver disease (ALD) and that the interferon regulatory factor 3 (IRF3),a transcription fa
132 rom the site of inoculation independently of interferon regulatory factor 3 (IRF3)-, IRF7-, and IFNAR
134 ation of toll-like receptor 4 (TLR4) and its interferon regulatory factor 3 (IRF3)-dependent downstre
136 identifies both inhibitors and activators of interferon regulatory factor 3 (IRF3)-mediated gene indu
145 IFN-beta promoter when it was stimulated by interferon regulatory factor 3 (IRF3)/5D or its upstream
146 ctivates the transcription factors NFkappaB, interferon regulatory factor-3 (IRF3) and CCAAA/enhancer
147 increased PTEN/TLR4 (Toll-like receptor 4), interferon regulatory factor-3 (IRF3), nuclear factor ka
149 lasmic viral PRR by triggering activation of interferon-regulatory factor 3 (IRF3) and production of
151 articular, expression and phosphorylation of interferon-regulatory factor 3 (IRF3) was decreased in E
152 Immediately upon entry, viruses activate interferon-regulatory factor 3 (IRF3), as well as nuclea
157 f interferon genes - tank-binding kinase 1 - interferon regulatory factor 3) pathway, shedding light
159 etion of the downstream transcription factor interferon regulatory factor 3 resulted in reduced induc
160 plex virus (HSV)-infected cells and initiate interferon regulatory factor-3 signaling, but it has bee
161 1)-AKT (AKT serine/threonine kinase 1)-IRF3 (interferon regulatory factor 3) signaling cascade leadin
162 hatase 2A (PP2A) as a deactivator of phospho-interferon regulatory factor 3, the key transcription fa
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。